CD44 and breast cancer: Upregulation of miR-495 was found in two BC stem cell (BCSC) populations (PROCR+/ESA+ and CD44+/CD24−low) and BC cell lines (MDA-MB-468, MDA-MB-361, and SKBR-3), enhancing colony formation in vitro and tumorigenesis in vivo [53].